Buchholz et al., 1995 - Google Patents
5-Fluorouracil-radiation interactions in human colon adenocarcinoma cellsBuchholz et al., 1995
View PDF- Document ID
- 4769895743285825673
- Author
- Buchholz D
- Lepek K
- Rich T
- Murray D
- Publication year
- Publication venue
- International Journal of Radiation Oncology* Biology* Physics
External Links
Snippet
Purpose: To determine the effect of cellular proliferation and cell cycle stage on the ability of postirradiation Sfluorouracil(5. FU) to radiosensitize cultured human colon adenocarcmoma Clone A cells. Methods and Materials: Cell survival curves were generated for irradiated:(a) …
- 201000010897 colon adenocarcinoma 0 title abstract description 5
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0009—Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation
- A61K41/0019—Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation by UV, IR, Rx or gamma rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kaplan et al. | Effect of halogenated pyrimidines on radiosensitivity of E. coli | |
| Kinsella et al. | Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs | |
| Iliakis et al. | Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on radiation induction of DNA and chromosome damage and its correlation with cell killing | |
| CN108030919B (en) | Preparation of human serum albumin-modified black phosphorus quantum dots and their application as sensitizers | |
| Buchholz et al. | 5-Fluorouracil-radiation interactions in human colon adenocarcinoma cells | |
| Lin et al. | Not all 2 Gray radiation prescriptions are equivalent: Cytotoxic effect depends on delivery sequences of partial fractionated doses | |
| Lawrence | Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression | |
| Mitchell et al. | Radiobiology and clinical application of halogenated pyrimidine radiosensitizers | |
| Iliakis et al. | Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on cell killing and interphase chromosome breakage in radiation-sensitive cells | |
| Cai et al. | Mild hyperthermia can induce adaptation to cytogenetic damage caused by subsequent X irradiation | |
| Miller et al. | Evaluation of incorporated iododeoxyuridine cellular radiosensitization by photon activation therapy | |
| Pettersen | Radiation-modifying effect of oxygen in synchronized cells pre-treated with acute or prolonged hypoxia | |
| Röttinger et al. | Modification of pH induced cellular inactivation by irradiation—Glial cells | |
| Kaplan | Analysis of the intracellular development of a DNA-containing mammalian virus (pseudorabies) by means of ultraviolet light irradiation | |
| Hughes et al. | Radiosensitization of cultured human colon adenocarcinoma cells by 5-fluorouracil: effects on cell survival, DNA repair, and cell recovery | |
| Iliakis et al. | Keynote address: application of non-hypoxic cell sensitizers in radiobiology and radiotherapy: rationale and future prospects | |
| Hemvanii et al. | Effect of helium-neon laser on cultured human macrophages | |
| Pardo et al. | Role of transfection and clonal selection in mediating radioresistance. | |
| Lohman et al. | The influence of 5-bromodeoxyuridine on the induction of breaks in the deoxyribonucleic acid of cultivated human cells by X-irradiation and ultraviolet light | |
| Kwok et al. | The radiation response of cells recovering after chronic hypoxia | |
| Shadley et al. | Evidence that the adaptive response of human lymphocytes to ionizing radiation acts on lethal damage in nonaberrant cells | |
| Iliakis et al. | Mechanism of radiosensitization by halogenated pyrimidines: bromodeoxyuridine and β-arabinofuranosyladenine affect similar subsets of radiation-induced potentially lethal lesions in plateau-phase Chinese hamster ovary cells | |
| Iliakis et al. | Repair and fixation of potentially lethal damage (PLD) as demonstrated by delayed plating or incubation with araA in contact inhibited refed plateau-phase C3H mouse embryo 10 T1/2 cells grown in the presence of BrdUrd | |
| Lehnert et al. | Low doses of ionizing radiation induce nuclear activity in human tumour cell lines which catalyses homologous double-strand recombination | |
| Aoyama et al. | Effect of halogenated pyrimidines on radiosensitivity of mouse strain L cells and their radioresistant variant |